Universitatsklinikum Aachen, Anstalt des offentlich
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Strnad, Pavel
NCT05899673: An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver Disease

Active, not recruiting
3
37
Europe, US
Fazirsiran Injection, TAK-999, ARO-AAT
Takeda
Alpha1-Antitrypsin Deficiency
05/26
05/26
NCT05677971: Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

Recruiting
3
160
Europe, Canada, US, RoW
Fazirsiran Injection, TAK-999, ARO-AAT, ADS-001, Placebo, Sodium chloride
Takeda, Takeda Development Center Americas, Inc.
Alpha1-Antitrypsin Deficiency
03/27
03/29
NCT06512454: A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems

Recruiting
N/A
1000
Europe, US
No Intervention
Takeda
Alpha1-Antitrypsin Deficiency
04/32
04/32
Kuerten, Melanie
No trials found

Download Options